Results 31 to 40 of about 48 (45)

PPFIA1-targeting miR-181a mimic and saRNA overcome imatinib resistance in BCR-ABL1-independent chronic myeloid leukemia by suppressing leukemia stem cell regeneration

Molecular Therapy - Nucleic Acids, 2023
Jia Fei, Xiuyuan Wang, Juhua Yang
exaly  

Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA

Journal of Controlled Release, 2019
Paul Mckay, Yoann Aldon, Robin Shattock   +2 more
exaly  

Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC

Molecular Therapy - Nucleic Acids, 2019
Kai-Wen Huang, Daniel Vasconcelos, Pinelopi Andrikakou   +2 more
exaly  

saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription

Cell Research, 2016
Long-Cheng Li, Kathy H Li, Burlingame Alma   +2 more
exaly  

Initial development of the Psychopathic Processing and Personality Assessment (PAPA) across populations

International Journal of Law and Psychiatry, 2017
Michael Lewis, Carol Ireland, Janice Abbott   +2 more
exaly  

Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA

Gene Therapy, 2019
Paul Mckay, Yoann Aldon, Robin Shattock   +2 more
exaly  

Sarna, diagnóstico, tratamiento y seguimiento

FMC Formacion Medica Continuada En Atencion Primaria, 2023
exaly  

A novel nucleolar protein, PAPA-1, induces growth arrest as a result of cell cycle arrest at the G1 phase

Gene, 2004
Hiroyoshi Ariga, Sanae M M Iguchi-Ariga, Takahiro Taira   +2 more
exaly  

Artificial Neutrophil-Mediated CEBPA-saRNA Delivery to Ameliorate ALI/ARDS

ACS Applied Materials & Interfaces
Lingmin Zhang, Aiping Qin, Shunqing Tang   +2 more
exaly  

Sarna ampollosa con respuesta terapéutica a la ivermectina

Actas Dermo-sifiliográficas, 2010
exaly